PPIPT00597
Target Protein Information
| Protein_Name | T cell receptor alpha chain constant |
|---|---|
| Protein_Sequence | IQNPDPAVYQLRDSKSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKTVLDMRSMDFKSNSAVAWSNKSDFACANAFNNSIIPEDTFFPSPESSCDVKLVEKSFETDTNLNFQNLSVIGFRILLLKVAGFNLLMTLRLWSS |
| Organism_Source | Homo sapiens |
| Functional_Classification | T-cell receptor constant region |
| Cellular_Localization | Plasma membrane |
| Gene_Names | TRAC |
| UniProt_ID | P01848 |
| Protein-Protein Interaction Networks | |
Peptide Basic Information
| Peptide_Name | ISU |
|---|---|
| Peptide_Sequence | LQARILAVERYLKDQQL |
| Peptide_Length | 17 |
| Peptide_SMILES | CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C |
| Chemical_Modification | None |
| Cyclization_Method | None |
| Linear/Cyclic | Cyclic |
| N-terminal_Modification | Free |
| C-terminal_Modification | Amide |
| Amino_Acid_Distribution | |
|
|
|
Peptide Physicochemical
| Molecular_Weight | 2057.42 |
|---|---|
| Aliphatic_Index | 143.52941 |
| Aromaticity | 0.05882 |
| Average_Rotatable_Bonds | 4.23529 |
| Charge_at_pH_7 | 0.99905 |
| Isoelectric_point | 9.29642 |
|---|---|
| Number_of_Hydrogen_Bond_Acceptors | 27 |
| Number_of_Hydrogen_Bond_Donors | 31 |
| Topological_Polar_Surface_Area | 902.84000 |
| X_logP_energy | -6.17876 |
Interaction Information
| Affinity | Ki=15 uM |
|---|---|
| Affinity_Assay | cell proliferation assay |
| PDB_ID | None |
| Type | Inhibitor |
| Structure | |
Reference Information
| Document_Type | Patent |
|---|---|
| Title | PEPTIDES DERIVED FROM HIV GP41 FOR TREATING T-CELL MEDIATED PATHOLOGIES |
| Release_Year | 2015 |
| Patent_ID | US20150175666A1 |